<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03343873</url>
  </required_header>
  <id_info>
    <org_study_id>2017-7-17</org_study_id>
    <nct_id>NCT03343873</nct_id>
  </id_info>
  <brief_title>The Effects of Different Anesthetics on Functional Connectivity</brief_title>
  <acronym>ACTION</acronym>
  <official_title>The Effects of Different Anesthetics on Functional Connectivity in Volunteers and Patients With Brain Tumor (ACTION)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is a prospective cohort study. The aim of the study is to determine different&#xD;
      levels of sedative mechanism and the effect on brain functional connectivity of midazolam,&#xD;
      dexmedetomidine and propofol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research will include 120 healthy volunteers and 120 brain tumor patients; the&#xD;
      participants will be allocated into midazolam, dexmedetomidine and propofol group. Resting&#xD;
      and task fMRI will be performed at awake (BIS&gt;90), mild sedation (BIS 80-85), moderate&#xD;
      sedation (BIS 65-75), deep sedation (BIS 45-55) and recovery states (BIS &gt;90). The primary&#xD;
      outcome of our study is the effect of different levels of sedation for brain network&#xD;
      connection. The secondary outcomes are the effect of different levels of sedation for&#xD;
      default, executive control, sensory and motor networks and their subnetwork connectivity; the&#xD;
      sedation state, circulatory and respiratory parameters of the participants, and the adverse&#xD;
      events.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitude of Low Frequency Fluctuations（ALLF）and Regional Homogeneity（ReHo)</measure>
    <time_frame>30mins after administration</time_frame>
    <description>The differences of amplitude of low frequency fluctuations (ALFF/Low Frequency Amplitude) and regional homogeneity（ReHo) in brain voxel - wise under anesthetic sedations.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Midarolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>midarolam sensation group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>propofol sensation group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine sensation group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam was administered intravenously at a dose of 0.1 mg / kg followed by continuous intravenous injection at 0.03 mg / kg / h and maintained until the course of the scan.</description>
    <arm_group_label>Midarolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol group 1mg / kg intravenous injection, followed by 2mg / kg / h continuous intravenous injection, and maintained to the scanning process;</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine group with total amount of 1μg / kg, infusion time 15min, followed by 0.6μg / kg / h, and maintained to the scanning process;</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. Male, 18 ~ 65 years old&#xD;
&#xD;
          -  2. Healthy Volunteer / Brain Tumor Patients&#xD;
&#xD;
          -  3. Senior high school and above&#xD;
&#xD;
          -  4. Sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. In vivo implant MRI check taboo&#xD;
&#xD;
          -  2. Cardiopulmonary liver and kidney and other systemic complications&#xD;
&#xD;
          -  3. History of major surgical anesthesia&#xD;
&#xD;
          -  4. Abuse of drugs, alcoholism history&#xD;
&#xD;
          -  5. Test drug allergy history&#xD;
&#xD;
          -  6. Claustrophobia&#xD;
&#xD;
          -  7. Left hand&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruquan Han, M.D., Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology, Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruquan Han, M.D., Ph.D</last_name>
    <phone>8610-67096660</phone>
    <email>ruquan.han@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Tian Tan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100070</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruquan Han, M.D., Ph.D</last_name>
      <phone>8610-59976660</phone>
      <email>ruquan.han@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 17, 2017</study_first_submitted>
  <study_first_submitted_qc>November 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>associated professor</investigator_title>
  </responsible_party>
  <keyword>anesthetics; fMRI; functional connectivity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

